To investigate the involvement of adaptive immunity in aFT effect against cancer, we measured CD8+ T lymphocytes-cytotoxicity against CT26.CL25 colon carcinoma cells using CD8+ T lymphocytes sorted from TILs 5 days after aFP treatment. This evidence concerns the gene CD8A and cancer.